期刊文献+

基质环形浸润性棘阿米巴角膜炎的治疗与分期初探 被引量:2

Acanthamoeba keratitis with ring-shaped stromal infiltration
下载PDF
导出
摘要 目的探讨有角膜环形基质浸润病变的棘阿米巴角膜炎的临床分期、治疗及预后。方法对17例(17眼)有角膜环形基质浸润病变的棘阿米巴角膜炎或合并真菌感染病例作了回顾性研究,根据角膜环形基质浸润的病程、环宽、浸润深浅、色泽分为早期和晚期,然后分别给予相应的药物和手术治疗。结果早期者8眼,药物治愈5眼,手术成功2眼,手术失败1眼;晚期者9眼,药物治愈2眼,手术成功5眼,手术失败2眼。结论早期诊断、正确分期及应用有效的药物治疗和选择适当的术式是成功治疗有环形基质浸润病变的棘阿米巴角膜炎的关键。 Objective Acanthamoeba keratitis,a severe corneal infective disease,is often caused by free-living amoeba Acanthamoeba. Ring-shaped stromal infiltrate is one of the distinguished clinical characteristics in Acanthamoeba keratitis. This study was to discuss the clinical progress,treatment,and prognosis of Acanthamoeba keratitis with ring-shaped stromal infiltration. Methods Seventeen eyes of 17 cases of Acanthamoeba keratitis with or without fungal infection were studied retrospectively. According to the onset time,size,depth and color of the lesion, ring-shaped stromal infiltrates were divided into two stages : early stage of lesion and late stage of one, and these lesions were managed by either medicine or surgery. Results In the early stage group (8 eyes) ,5 eyes got recovery by regents and 2 eyes by surgery,but 1 eye was not responded to the treatment. In the late stage group (9 eyes) , 2 eyes were recovered by pharmaceutical administration and the other 5 eyes by operation. No enough effectiveness was observed on the rest 2 eyes. Conclusion An early diagnosis,distinguishing stages correctly,administrating effective agents and selecting appropriate surgeries are crucial for the treatment of Acanthamoeba keratitis with ring-shaped stromal infiltration.
出处 《眼科研究》 CSCD 北大核心 2007年第9期685-687,共3页 Chinese Ophthalmic Research
关键词 角膜浸润 棘阿米巴角膜炎 临床特征 预后 ring-shaped stromal infiltration Acanthemoeba keratitis clinical characteristics prognosis
  • 相关文献

参考文献10

  • 1Kamel AG,Faridah H,Yusof S,et al.A case of trauma related Acanthamoeba keratitis[J].Trop Biomed,2004,21:135-138
  • 2Sun X,Zhang Y,Li R,et al.Acanthamoeba keratitis:clinical characteristics and management[J].Ophthalmology,2006,113:412-416
  • 3Schaumberg DA,Snow KK,Dana MR.The epidemic of Acanthamoeba keratitis:where do we stand[J]? Cornea,1998,17:3-10
  • 4邓新国,李家臣,赵东卿,祝磊.棘阿米巴角膜炎的临床表现及病理特征[J].眼科研究,2000,18(6):527-529. 被引量:7
  • 5金秀英,罗时运,杨宝铃,张文华,邹洋,李彬,李辽青,王正仪.棘阿米巴角膜炎的诊断和治疗探讨[J].眼科研究,2000,18(2):143-145. 被引量:29
  • 6Theodore FH,Jakobiec FA,Juechter KB,et al.The diagnosis value of a ring infiltrate in Acanthamoeba keratitis[J].Ophthalmology,1985,92:1471-1479
  • 7Bacon AS,Dart JKG,Ficker LA,et al.Acanthamoeba keratitis:the value of early diagnosis[J].Ophthalmology,1993,100:1238-1243
  • 8Awwad ST,Parmar DN,Heilman M,et al.Results of penetrating keratoplasty for visual rehabilitation after Acanthamoeba keratitis[J].Am J Ophthalmol,2005,140:1080-1084
  • 9Ficker LA,Kirkness C,Wright P.Prognosis for keratoplasty in Acanthamoeba keratitis[J].Ophthalmology,1992,100:105-110
  • 10Peterson RJ,Smith ME,Pepose JS.Recurrent Acanthamoeba keratitis following penetrating keratoplasty[J].Arch Ophthalmol,1990,108:1482-1483

二级参考文献5

共引文献30

同被引文献37

  • 1史伟云,高华,李绍伟,王富华,谢立信.穿透性角膜移植治疗棘阿米巴角膜炎的临床研究[J].中华眼科杂志,2004,40(11):750-754. 被引量:18
  • 2王冰,王传富,朱学军.甲硝唑治疗棘阿米巴角膜炎的临床观察[J].中国实用眼科杂志,2006,24(2):222-223. 被引量:2
  • 3Shi W, Liu M, Gao H, Xie L. Perioperative treatment and prog-nostic factors for penetrating keratoplasty in 4. Acanthamoebakeratitis unresponsive to medical treatment [ J]. Graefes ArchClin Exp Ophthalmol,2009,247 (10):1383-1388.
  • 4Radford CF,Minassian DC,Dart JK. Acanthamoeba keratitis inEngland and Wales: incidence,outcome,and risk factors [J]. BrJ Ophthalmol,2002,86 (5):536-542.
  • 5Joslin CE,Tu EY, McMahon TT,Passaro DJ, Stayner LT, SugarJ. Epidemiological characteristics of a Chicago-area Acan-thamoeba keratitis outbreak [ J ]. Am J Ophthalmol, 2006, 142(2):212-217.
  • 6Wilhelmus KR. Introduction: the increasing importance of Acan-thamoeba[ J J. Rev Infect Dis,1991,13( suppl 5) ; S367-368.
  • 7Lam DS,Houang E, Fan DS, Lyon D,Seal D,Wong E. HongKong Microbial Keratitis Study Group. Incidence and risk factorsfor microbial keratitis in Hong Kong: comparison with Europeand North America[ J]. Eye,2002,16(5):608-618.
  • 8Murdoch D,Gray TB,Cursons R,Parr D. Acanthamoeba keratitisin New Zealand, including two cases with in vivo resistance topolyhexamethylene biguanide[ J]. Aust NZJ Ophthalmol,1998,26(3):231-236.
  • 9Claerhout I,Goegebuera A,Van Den Broecke C,Kestelyn P. De-lay in diagnosis and outcome of Acanthamoeba keratitis [ J ].Graefes Arch Clin Exp Ophthalmol,2004,242(8):648-653.
  • 10Ficker L, Kirkness C, Wright P. Prognosis for keratoplasty inAcanthamoeba keratitis [J ]. Ophthalmology,1993,100 ( 1): 105-110.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部